Research sheds new light on how the body converts the bad kind of cholesterol. The discovery could lead to new and potentially more effective medicine.
Again and again, it’s the rare among humans that help the rest of us. The exploration of human genetics is revealing new targets to combat heart disease among atypical variants. Mutations in genes that play a role in heart health are the inspiration for a cluster of new heart drugs.
When is high HDL cholesterol good, and is higher always better? Learn how to find the right balance along with some healthful ways to achieve high HDL.
In a large analysis of genetic data, a team has first looked into what causes type 2 diabetes (T2D) and second clarified how T2D and coronary heart disease (CHD) -- the two diseases that are the leading cause of global morbidity and mortality, are linked.
Most of us discard avocado seeds without a second thought, but a new study finds that the husk of these seeds may hold a treasure trove of health benefits.
PCSK9 inhibition could ameliorate atherosclerosis and thus cardiovascular disease by immune mechanisms that are unrelated to lowering of low-density lipoprotein (LDL) cholesterol, according to new research.
Researchers are calling for a reconsideration of global dietary guidelines in light of new data on fat intake and cardiovascular risk and early mortality.
Investigators have announced results of a clinical trial culminating from 25 years of cardiovascular research work. The team reports a significant reduction in risk of recurrent heart attacks, strokes and cardiovascular death among participants who received a targeted anti-inflammatory drug that lowered inflammation but had no effects on cholesterol.
10 to 20 percent of patients taking statins report muscle-related symptoms including aches, pains and cramps that prevent the use of recommended doses. Patients who have difficulty taking statins have a high risk of cardiovascular events, resulting in higher health care costs. To address these concerns, researchers are providing approaches to optimize cardiovascular risk reduction for these patients.
Metabolically healthy obese adults consuming a diet high in unsaturated fat and low in saturated fat may be able to decrease their total cholesterol by 10 points, a new study suggests. However, there was little research evidence to support current dietary recommendations that replacing saturated fat with unsaturated fat aids in weight loss, the researchers also reported.
Study of 14 years of data on 1 million people found significantly lower odds of breast cancer and premature death in women diagnosed with high cholesterol.
Inflammatory hypothesis confirmed: Landmark randomized clinical trial of high-risk patients finds that a drug targeting inflammation reduced risk of major adverse cardiovascular events.
New analysis shows that in a high-risk population, achieving ultra-low LDL cholesterol levels, down to less than 10 mg/dL, safely results in additional lowering of risk of cardiovascular events.
In overweight and obese children and adolescents, vitamin D deficiency is associated with early markers of cardiovascular disease, a new study reports.
Body weight plays a significant role in how much benefit children may get from consuming “good” fats, new research suggests. The study highlights the need for weight-appropriate dosing of supplements and medications.
Cardiac glycosides reduce a precursor of LDL cholesterol in a drug screen of statin-resistant hypercholesterolemia, new research concludes. A large meta-analysis of medical records revealed that patients taking glycosides for heart failure had reductions in LDL cholesterol similar to patients taking statins. Cardiac glycosides are a potential treatment for patients with high cholesterol who don't respond to statins.
